Back
Givaudan SA Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
77
GVDNY
Givaudan SA
Last Price:
$92.84
Seasonality Move:
2.34%
Sell
27
CRSP
CRISPR Therapeutics AG
Last Price:
$37.78
Seasonality Move:
21.79%
Buy
77
Givaudan SA (GVDNY)
is a Buy
Is Givaudan SA a Buy, Sell or Hold?
-
The current Givaudan SA [GVDNY] share price is $92.84. The Score for GVDNY is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
GVDNY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $37.77. The Score for CRSP is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GVDNY Stock Price Chart
What is Givaudan SA's stock price today?
-
The Givaudan SA share price today is $92.84Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GVDNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $37.77Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.
GVDNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.87 | Buy |
| Relative Strength Index (14 RSI): | 59.41 | Buy |
| Chaikin Money Flow: | 11198 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (85.71 - 91.31) | Buy |
| Bollinger Bands (100): | (85.76 - 90.26) | Buy |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.36 | Buy |
| Relative Strength Index (14 RSI): | 49.46 | Sell |
| Chaikin Money Flow: | 99115 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.98 - 41.22) | Buy |
| Bollinger Bands (100): | (37.58 - 47.38) | Sell |
GVDNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 89.96 | Buy |
| 20-day SMA: | 88.04 | Buy |
| 50-day SMA: | 88.38 | Buy |
| 200-day SMA: | 93.42 | Sell |
| 8-day EMA: | 90.58 | Buy |
| 20-day EMA: | 89.21 | Buy |
| 50-day EMA: | 88.7 | Buy |
| 200-day EMA: | 89.93 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.63 | Buy |
| 20-day SMA: | 36.55 | Buy |
| 50-day SMA: | 40.9 | Sell |
| 200-day SMA: | 46.21 | Sell |
| 8-day EMA: | 36.89 | Buy |
| 20-day EMA: | 32.04 | Buy |
| 50-day EMA: | 20.78 | Buy |
| 200-day EMA: | 6.95 | Buy |
Givaudan SA Earnings Growth & GVDNY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.02 per share, an increase this year of $0.20 per share, and an increase next year of $0.91 per share.
Givaudan SA Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||